Led by Senior Intelligence Analyst Nikhil Krishnan
CBINSIGHTS | JULY 23, 2018 – In January of 2018, Amazon announced that they were planning to make moves in healthcare by partnering with JP Morgan and Berkshire Hathaway but specific details were scant.
In the last month the company made a ~$1B acquisition of mail-order pharmacy PillPack and appointed Atul Gawande to lead the initiative, making it clear that they were serious and were planning to move quickly. Wall Street did not look favorably for healthcare incumbents.
We analyze some of the rumored projects they’re working on as well as areas of healthcare we think are particularly vulnerable to Amazon’s entrance.
In this briefing, we discuss:
- Advantages, Philosophy, and Approach
- Where Amazon Should Enter Healthcare
- Amazon, the Pharmacy
- Claims Administration and Health Benefits Management
- Amazon and Medicare/Medicaid management
- Amazon for Providers
- Amazon in the Lab